Sa1458 Biodegradable Stents Are Superior to Fully Covered Metal Stents in the Endoscopic Management of Refractory Benign Esophageal Strictures: a Meta-Analysis

2013 ◽  
Vol 77 (5) ◽  
pp. AB213-AB214
Author(s):  
Stephen Kim ◽  
Martijn G. Van Oijen ◽  
Nikhil Agarwal ◽  
Chris M. Hamerski ◽  
Rabindra R. Watson ◽  
...  
2016 ◽  
Vol 07 (01) ◽  
pp. 001-005 ◽  
Author(s):  
Gopal Goyal ◽  
Surender Sultania ◽  
Babulal Meena ◽  
Sandeep Nijhawan

AbstractRefractory benign esophageal stricture (RBES) is a frequently encountered problem worldwide. These strictures arise from various causes such as corrosive injury, radiation therapy, peptic origin, ablative therapy, and after surgery. Most strictures can be treated successfully with endoscopic dilatation using bougies or balloons, with only a few complications. Those patients who fail after serial dilatation with bougies or balloons will come to the category of refractory strictures. Dilatation combined with intralesional steroid injections can be considered for peptic strictures, whereas incisional therapy has been demonstrated to be effective for short anastomotic strictures. When these therapeutic options do not resolve the stenosis, stent placement should be considered. Self-bougienage can be proposed to a selected group of patients with a proximal stenosis. Most of the patients of RBES respond to above-mentioned treatment and occasional patient may require surgery as the final treatment option. This review aims to provide a comprehensive approach toward endoscopic management of RBESs based on current literature and personal experience.


2021 ◽  
Vol 11 (1) ◽  
Author(s):  
Xing Wang ◽  
Haifeng Liu ◽  
Zhihong Hu ◽  
Rufang Zhang ◽  
Zhujun Gu ◽  
...  

AbstractTo share our institutional experience of placing individually designed fully covered self-expandable metal stents (FCSEMSs) for the treatment of refractory benign esophageal strictures (RBESs) in pediatric patients. A 10-year retrospective study between May 2009 and July 2020 that includes 14 children with RBESs who were treated with individually designed FCSEMSs. Patients were followed-up regularly after stent placement to observe the improvement of vomiting and dysphagia, changes in stenosis diameter and complications. A total of 20 stents were successfully placed in 14 patients. During a follow-up period ranging from 5 to 83 months, except for one 4-year-old child who could not endure chest pain, the remaining 13 patients all benefited from stenting. Their Ogilvie & Atkinson scores improved from grade III–IV to grade 0-I, and the diameters of the stenosis’ were enlarged from 2–5 mm to 9–14 mm. Two patients developed restenosis and granulation tissue hyperplasia was found in 2 patients and stent migration and malapposition in 2 patients with esophageal perforations that required further endoscopic intervention. The use of FCSEMS for RBES is safe and effective in selected pediatric patients. Rationally designed stents and timely management of postoperative complications are critical to ensure the success of this new method.


Sign in / Sign up

Export Citation Format

Share Document